About
Biotricity Inc. is a publicly traded medical technology company based in Redwood City, California. Founded in 2010, it specializes in Technology-as-a-Service (TaaS) solutions for remote biometric data monitoring, focusing on cardiac diagnostics and chronic care management. The company went public in 2015 and has shown significant growth, reporting revenues of $12.1 million in 2023. Biotricity offers a range of FDA-cleared products, including the Bioflux® mobile cardiac telemetry device, Biocore Holter monitors, and the Biocare platform for chronic care management. These solutions are designed for medical professionals and consumers, supporting remote monitoring and improving cardiac health. The company operates in two main segments: Technology Fees for recurring monitoring services and Device Sales for its wearable hardware. Biotricity aims to enhance patient self-management and address the growing demand for telehealth services.